01.08.2005
BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)
Erschienen in: Investigational New Drugs | Ausgabe 4/2005
Einloggen, um Zugang zu erhalten